Category: Pharmaceutical Policy

Prior Authorization for NTI Drugs: When Insurers Require Brands

Learn about prior authorization for NTI drugs, why insurers require brand names, and how to navigate the process. Discover the risks of delays and new regulations protecting patient access.

Extra Help Program for Low-Income Seniors: How to Qualify in 2026

Learn how to qualify for the Extra Help Program (LIS) to lower your Medicare Part D medication costs. Check 2026 income limits, resource rules, and how to apply.

Understanding Controlled Substance Labels and Schedule Codes

Learn how controlled substance labels and DEA schedule codes work. Understand the difference between Schedule I-V drugs and how they affect your prescriptions.

How to Evaluate Generic Drug Coverage When Switching Health Plans

Learn how to evaluate generic drug coverage and insurance formularies when switching health plans to avoid surprise costs and maximize savings.

180-Day Exclusivity and Authorized Generics: Legal Considerations Guide

Explore the legal clash between 180-day exclusivity and authorized generics. Understand how brand-name strategies impact generic profits and patient costs.